These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 10682387)
1. Disease-induced alterations in plasma drug-binding proteins and their influence on drug binding percentages in dogs. Ikenoue N; Saitsu Y; Shimoda M; Kokue E Vet Q; 2000 Jan; 22(1):43-9. PubMed ID: 10682387 [TBL] [Abstract][Full Text] [Related]
2. Supplemental Analysis of the Prediction of Hepatic Clearance of Binary Mixtures of Bisphenol A and Naproxen Determined in an Isolated Perfused Rat Liver Model to Promote the Understanding of Potential Albumin-Facilitated Hepatic Uptake Mechanism. Poulin P; Bteich M; Haddad S J Pharm Sci; 2017 Nov; 106(11):3207-3214. PubMed ID: 28823401 [TBL] [Abstract][Full Text] [Related]
3. Protein binding of fentanyl and its metabolite nor-fentanyl in human plasma, albumin and α-1 acid glycoprotein. Bista SR; Haywood A; Hardy J; Lobb M; Tapuni A; Norris R Xenobiotica; 2015 Mar; 45(3):207-12. PubMed ID: 25314012 [TBL] [Abstract][Full Text] [Related]
4. Plasma protein binding of drugs after severe burn injury. Martyn JA; Abernethy DR; Greenblatt DJ Clin Pharmacol Ther; 1984 Apr; 35(4):535-9. PubMed ID: 6705453 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of in vitro drug interactions with karenitecin, a novel, highly lipophilic camptothecin derivative in phase II clinical development. Smith JA; Newman RA; Hausheer FH; Madden T J Clin Pharmacol; 2003 Sep; 43(9):1008-14. PubMed ID: 12971034 [TBL] [Abstract][Full Text] [Related]
6. Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide. Bredesen JE; Kierulf P Br J Clin Pharmacol; 1984 Nov; 18(5):779-84. PubMed ID: 6508986 [TBL] [Abstract][Full Text] [Related]
7. Species differences in plasma protein binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease inhibitor nirmatrelvir. Greenfield SR; Eng H; Yang Q; Guo C; Byrnes L; Dantonio A; West G; Di L; Kalgutkar AS Xenobiotica; 2023 Jan; 53(1):12-24. PubMed ID: 36803165 [TBL] [Abstract][Full Text] [Related]
8. Plasma protein binding of quinine: binding to human serum albumin, alpha 1-acid glycoprotein and plasma from patients with malaria. Wanwimolruk S; Denton JR J Pharm Pharmacol; 1992 Oct; 44(10):806-11. PubMed ID: 1360505 [TBL] [Abstract][Full Text] [Related]
9. Human alpha-1-glycoprotein and its interactions with drugs. Israili ZH; Dayton PG Drug Metab Rev; 2001 May; 33(2):161-235. PubMed ID: 11495502 [TBL] [Abstract][Full Text] [Related]
10. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights. Poulin P; Haddad S J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347 [TBL] [Abstract][Full Text] [Related]
11. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs. Morse DS; Abernethy DR; Greenblatt DJ Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of carbamazepine and carbamazepine-epoxide protein binding in patients undergoing epilepsy surgery. Gidal BE; Spencer NW; Maly MM; Pitterle ME Epilepsia; 1996 Apr; 37(4):381-5. PubMed ID: 8603645 [TBL] [Abstract][Full Text] [Related]
14. Serum protein binding of tolterodine and its major metabolites in humans and several animal species. Påhlman I; Gozzi P Biopharm Drug Dispos; 1999 Mar; 20(2):91-9. PubMed ID: 10206324 [TBL] [Abstract][Full Text] [Related]
15. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure. Zini R; Morin D; Salvadori C; Tillement JP Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464 [TBL] [Abstract][Full Text] [Related]
16. Altered protein binding of quinidine in patients with atrial fibrillation and flutter. McCollam PL; Crouch MA; Watson JE Pharmacotherapy; 1997; 17(4):753-9. PubMed ID: 9250553 [TBL] [Abstract][Full Text] [Related]
17. Elevated plasma alpha 1-acid glycoprotein levels: lack of connection to resistance to vecuronium blockade induced by anticonvulsant therapy. Hans P; Brichant JF; Pieron F; Pieyns P; Born JD; Lamy M J Neurosurg Anesthesiol; 1997 Jan; 9(1):3-7. PubMed ID: 9016432 [TBL] [Abstract][Full Text] [Related]
18. Mechanistic investigations into the species differences in pinometostat clearance: impact of binding to alpha-1-acid glycoprotein and permeability-limited hepatic uptake. Smith SA; Gagnon S; Waters NJ Xenobiotica; 2017 Mar; 47(3):185-193. PubMed ID: 27160567 [TBL] [Abstract][Full Text] [Related]
19. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor. Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527 [TBL] [Abstract][Full Text] [Related]
20. Implications of plasma protein binding for pharmacokinetics and pharmacodynamics of the γ-secretase inhibitor RO4929097. Wu J; Lorusso PM; Matherly LH; Li J Clin Cancer Res; 2012 Apr; 18(7):2066-79. PubMed ID: 22351688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]